Double blind comparison of omeprazole (40 mg od) versus cimetidine (400 mg qd) in the treatment of symptomatic erosive reflux oesophagitis, assessed endoscopically, histologically and by 24 h pH monitoring.

Double blind comparison of omeprazole (40 mg od) versus cimetidine (400 mg qd) in the treatment of symptomatic erosive reflux oesophagitis, assessed endoscopically, histologically and by 24 h pH monitoring.

Item

http://www.wikidata.org/entity/Q34392553

Q34392553

about

Medical treatments in the short term management of reflux oesophagitis Medical treatments in the short term management of reflux oesophagitis Anti-relaxation therapy in GORD Omeprazole and high dose ranitidine in the treatment of refractory reflux oesophagitis.Long-term prescribing of proton pump inhibitors in general practice Pharmacoeconomic issues of the treatment of gastroesophageal reflux disease.Relation between oesophageal acid exposure and healing of oesophagitis with omeprazole in patients with severe reflux oesophagitis.What is heartburn worth? A cost-utility analysis of management strategies Role of gastric acid suppression in the treatment of gastro-oesophageal reflux disease.Mucin gene expression in Barrett's oesophagus: an in situ hybridisation and immunohistochemical study.Effect of the GABA(B) agonist baclofen in patients with symptoms and duodeno-gastro-oesophageal reflux refractory to proton pump inhibitors A systematic review of symptomatic outcomes used in oesophagitis drug therapy trials.General surgery Clinical pharmacology and therapeutics.Comparative role of omeprazole in the treatment of gastroesophageal reflux disease.Assessment of the environmental risk factors for a gastric ulcer in northern Ghana Response of regurgitation to proton pump inhibitor therapy in clinical trials of gastroesophageal reflux disease.Gastro-oesophageal reflux. Part 2: medical treatment.Bile acid at low pH reduces squamous differentiation and activates EGFR signaling in esophageal squamous cells in 3-D culture.PPI therapy is equally effective in well-defined non-erosive reflux disease and in reflux esophagitis: a meta-analysis.Head-to-head comparison of H2-receptor antagonists and proton pump inhibitors in the treatment of erosive esophagitis: a meta-analysis.Oesophageal candidiasis after omeprazole therapy.Bile Salts at Low pH Cause Dilation of Intercellular Spaces in In Vitro Stratified Primary Esophageal Cells, Possibly by Modulating Wnt Signaling.Economic analysis of step-wise treatment of gastro-oesophageal reflux disease.Interobserver variation in the endoscopic diagnosis of reflux esophagitis.Pilot, Randomized, Blinded, Placebo-Controlled Trial Investigating the Correlation Between Acid Control and Heartburn Relief with 14 Days of Esomeprazole Treatment

P2860

Q24234225-0C2629F5-D0CF-4E51-8585-E0201D9B7761 Q24245220-1E340DB7-5867-4DD5-856E-BAFABEC2E381 Q28344333-BE6BC74C-FFAC-4CF8-8B6E-02E039A6F3A0 Q33624127-4F71F5A7-7BDA-4638-B3C3-560D28C278D9 Q34217020-DEA56C5C-1561-4AE3-8861-63C66702BF34 Q34388572-7A2F9A93-22E2-42F8-BBCB-EB24489F8393 Q34409644-CB7BEF10-F5BA-468F-8891-EDA3A5247C3D Q34745082-51388484-40E5-49EC-868B-5DF32E2EA924 Q35250682-A8300336-8BCD-40CC-8C69-C940C09B4BF1 Q35362159-C1B3BF54-4644-40F8-A6AD-BAB3BA9204C6 Q35596016-9146968F-F8F8-4DDC-BEF1-D32228FDF57E Q35745058-417838D7-E746-443D-BB1B-D034F6A60F7B Q36682325-A77EF48A-9EB6-4C87-8974-C91517C10D63 Q36682367-78C75CED-EBD6-4CEA-9E59-46C102E3AAAE Q36803997-5B5BA1B6-6607-473E-867A-CE572242F665 Q37666625-C52AAED7-9659-4CCA-AB13-289470D5C79C Q37871345-8BCD9670-E3C5-4DDD-89A3-CB93D2B94906 Q38094883-09CC852E-4789-4295-8247-1BB3BFFA4086 Q39114318-9F806FED-AD70-43AB-92CF-6C89D9EDADEA Q39252347-DC928475-BD8D-4575-AFFD-003D0530AD12 Q41560226-730437B9-773E-4FA5-8D53-F400AEDA9F14 Q43221363-8C6A13D4-9F5A-4B53-8B06-230522ED4E6C Q45024270-1BA7D090-7D9F-4DE3-9737-08C48D06534F Q52205947-0725F9BA-E232-4D23-97ED-8B8C2B99D21D Q52885768-C9BB178A-514A-40D1-A2CF-B02F1B2532C4 Q59130504-0E8383D0-4B9B-40D0-88ED-7BCC132B8682

P2860

Double blind comparison of omeprazole (40 mg od) versus cimetidine (400 mg qd) in the treatment of symptomatic erosive reflux oesophagitis, assessed endoscopically, histologically and by 24 h pH monitoring.

Item

http://www.wikidata.org/entity/Q34392553

description

1990 nî lūn-bûn

@nan

1990 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

1990 թվականի մայիսին հրատարակված գիտական հոդված

@hy

1990年の論文

@ja

1990年論文

@yue

1990年論文

@zh-hant

1990年論文

@zh-hk

1990年論文

@zh-mo

1990年論文

@zh-tw

1990年论文

@wuu